Search research articles
Contact Us
Filters
Showing results (1-10 of 213) with videos related to
Page
of 22
Sort By:
Oncotarget
|
November 16, 2017
Taking it up a NOTCH: a novel subgroup of ACC is identified
Renata Ferrarotto, John V Heymach
Expert Opinion on Investigational Drugs
|
November 26, 2013
Afatinib in the treatment of head and neck squamous cell carcinoma
Renata Ferrarotto, Kathryn A Gold
Clinical Colorectal Cancer
|
July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilities
Renata Ferrarotto, Paulo M Hoff
Expert Review of Anticancer Therapy
|
October 25, 2021
Pembrolizumab in the first-line treatment of advanced head and neck cancer
Luana Guimaraes de Sousa, Renata Ferrarotto
Oncotarget
|
November 22, 2024
B7-H4: A potential therapeutic target in adenoid cystic carcinoma
Luana Guimaraes de Sousa, Renata Ferrarotto
Therapeutic Advances in Medical Oncology
|
November 2, 2016
Checkpoint inhibitors in lung cancer: latest developments and clinical potential
Gustavo Schvartsman, Renata Ferrarotto, Erminia Massarelli
Expert Review of Anticancer Therapy
|
April 28, 2023
Targeting human EGFR 2 (HER2) in salivary gland carcinoma
Michael Wotman, Adel El-Naggar, Renata Ferrarotto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2015
New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic
Erminia Massarelli, Renata Ferrarotto, Bonnie S Glisson
Expert Opinion on Emerging Drugs
|
May 5, 2023
New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma
Flavia Bonini, Luana Guimarães de Sousa, Renata Ferrarotto
Current Opinion in Oncology
|
March 15, 2016
MYB-fusions and other potential actionable targets in adenoid cystic carcinoma
Renata Ferrarotto, John V Heymach, Bonnie S Glisson
Page
of 22
Search research articles
Search
Showing results (1-10 of 213) with videos related to
Sort By:
Page
of 22
Oncotarget
|
November 16, 2017
Taking it up a NOTCH: a novel subgroup of ACC is identified
Renata Ferrarotto, John V Heymach
Expert Opinion on Investigational Drugs
|
November 26, 2013
Afatinib in the treatment of head and neck squamous cell carcinoma
Renata Ferrarotto, Kathryn A Gold
Clinical Colorectal Cancer
|
July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilities
Renata Ferrarotto, Paulo M Hoff
Expert Review of Anticancer Therapy
|
October 25, 2021
Pembrolizumab in the first-line treatment of advanced head and neck cancer
Luana Guimaraes de Sousa, Renata Ferrarotto
Oncotarget
|
November 22, 2024
B7-H4: A potential therapeutic target in adenoid cystic carcinoma
Luana Guimaraes de Sousa, Renata Ferrarotto
Therapeutic Advances in Medical Oncology
|
November 2, 2016
Checkpoint inhibitors in lung cancer: latest developments and clinical potential
Gustavo Schvartsman, Renata Ferrarotto, Erminia Massarelli
Expert Review of Anticancer Therapy
|
April 28, 2023
Targeting human EGFR 2 (HER2) in salivary gland carcinoma
Michael Wotman, Adel El-Naggar, Renata Ferrarotto
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2015
New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic
Erminia Massarelli, Renata Ferrarotto, Bonnie S Glisson
Expert Opinion on Emerging Drugs
|
May 5, 2023
New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma
Flavia Bonini, Luana Guimarães de Sousa, Renata Ferrarotto
Current Opinion in Oncology
|
March 15, 2016
MYB-fusions and other potential actionable targets in adenoid cystic carcinoma
Renata Ferrarotto, John V Heymach, Bonnie S Glisson
Page
of 22